Novotech Health Holdings Pte, a clinical research and testing provider backed by private equity firm TPG and Singapore sovereign wealth fund GIC Pte, swung back into profit in 2022 after posting higher revenues.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
